| A.M. Pappas & Associates LLC |
Art Pappas |
| Abingworth Management Inc |
Jonathan MacQuitty |
| Acorda Therapeutics, Inc. |
Ron Cohen |
| Alloy Ventures, Inc. |
J. Leighton Read |
| Alloy Ventures, Inc. |
Craig Taylor |
| Alta Partners |
Farah Champsi |
| Anthem Capital Management, LLC. |
Gerry Schaafsma |
| Aphelion Capital |
Rodney Altman |
| Atlas Venture |
Peter Barrett |
| Atlas Venture |
Jean-Francois Formela |
| Bank of America |
Andrew Weisenfeld |
| Barrier Therapeutics, Inc. |
Geert Cauwenbergh |
| Bay City Capital LLC |
Jeanne Cunicelli |
| BioCentury Publications Inc. |
Karen Bernstein |
| Burrill & Company |
G. Steven Burrill |
| BVF Partners, L.P. |
Matthew Perry |
| CIBC World Markets |
Peter Crowley |
| CIBC World Markets |
Matthew Plunkett |
| Cooley Godward LLP |
Barbara Kosacz |
| Cytokinetics, Inc. |
James Sabry |
| Delphi Ventures L.P. |
Deepa Pakianathan |
| Domain Associates, L.L.C. |
Bob More |
| Equity4Health LLC |
Vera Kallmeyer |
| Ernst & Young LLP |
Michael Hildreth |
| Five Prime Therapeutics, Inc. |
Gail Maderis |
| Frazier Healthcare Ventures |
Robert Overell |
| Genesys Capital Partners Inc |
Kelly Holman |
| GlycoMimetics, Inc. |
Rachel King |
| Heller Ehrman LLP |
Bruce Jenett |
| InterWest Partners |
Chris Ehrlich |
| Jazz Pharmaceuticals, Inc. |
Samuel Saks |
| Jefferies |
Annette Grimaldi |
| J.P. Morgan Partners, LLC |
Rodney Ferguson |
| Kilkenny Capital Management, L.L.C. |
Vincent Aita |
| Kleiner Perkins Caufield & Byers |
Brook Byers |
| L Capital Partners |
Ting Pau Oei |
| Lehman Brothers |
Matthew P. Young |
| MDS Capital Corp. |
Nandini Tandon |
| Merck & Co., Inc. |
Pamela Demain |
| Morgenthaler Ventures |
Ralph (Chris) Christoffersen |
| MPM Capital L.P. |
Ashley Dombkowski |
| New Enterprise Associates |
Michael Raab |
| New Enterprise Associates |
Chris Shen |
| Onyx Pharmaceuticals, Inc. |
Hollings Renton |
| OrbiMed Advisors, LLC |
Michael Sheffery |
| Oxford Bioscience Partners |
Mark Carthy |
| Oxford Bioscience Partners |
Douglas Fambrough |
| Oxford Bioscience Partners |
Michael Lytton |
| Pequot Capital Management, Inc. |
Gregory Martinez |
| Pequot Ventures |
Marc-Henri Galletti |
| Perseus-Soros BioPharmaceutical Fund, L.P. |
Christopher Earl |
| Perseus-Soros BioPharmaceutical Fund, L.P. |
Dennis Purcell |
| Prospect Venture Partners |
Alex Barkas |
| PTV Sciences L.P. |
Evan Melrose |
| Quaker BioVentures, Inc. |
P. Sherrill Neff |
| RBC Capital Markets |
Andrew Singer |
| SV Life Sciences |
Mike Ross |
| Scios Inc. |
George Schreiner |
| Signals Magazine |
Jennifer Van Brunt |
| Skyline Ventures |
John Freund |
| Sofinnova Ventures, Inc. |
Nicola Campbell |
| Solexa, Inc. |
Linda Rubinstein |
| Stanford University |
Phyllis Gardner |
| StemCells, Inc. |
Martin McGlynn |
| Sunesis Pharmaceuticals, Inc. |
Daniel Swisher, Jr. |
| T. Rowe Price Associates |
Jay Markowitz |
| Venrock Associates |
Bryan Roberts |
| Ventures West Management, Inc. |
Nancy Harrison |
| Versant Ventures |
Brian Atwood |
| Versant Ventures |
Camille Samuels |
| Warburg Pincus LLC |
Jonathan Leff |
